1 BTC
=
- USD
R1 RCM Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About R1 RCM Inc. Common Stock
R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.
Market Statistics
Trading Metrics
How to Buy RCM
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy RCM
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesThe global healthcare revenue cycle management market is expected to grow from $169.70 billion in 2025 to $453.47 billion by 2034, driven by the shift towards value-based care and increasing demand for integrated solutions. However, data privacy and security concerns remain a restraint.
Brodsky & Smith is investigating the proposed acquisitions of R1 RCM Inc., Enstar Group Limited, Premier Financial Corp., and The First Bancshares, Inc. to determine if the respective boards breached their fiduciary duties by failing to conduct a fair process and ensure shareholders are receiving fair value.
The law firm of Wohl & Fruchter LLP is investigating the fairness of the sale of R1 RCM to TowerBrook Capital Partners and Clayton, Dubilier & Rice for $14.30 per share, which is below the price targets set by Wall Street analysts.